X4 Pharmaceuticals Correlations

XFOR Stock  USD 0.31  0.01  3.33%   
The current 90-days correlation between X4 Pharmaceuticals and PDS Biotechnology Corp is 0.19 (i.e., Average diversification). The correlation of X4 Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

X4 Pharmaceuticals Correlation With Market

Significant diversification

The correlation between X4 Pharmaceuticals and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in X4 Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.

Moving together with XFOR Stock

  0.81CDIOW Cardio DiagnosticsPairCorr
  0.76ELVN Enliven TherapeuticsPairCorr
  0.74SCLX Scilex HoldingPairCorr
  0.84ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.7CDIO Cardio DiagnosticsPairCorr
  0.62CMND Clearmind Medicine CommonPairCorr
  0.82CRNX Crinetics PharmaceuticalsPairCorr
  0.68DIS Walt DisneyPairCorr
  0.72MSFT MicrosoftPairCorr

Moving against XFOR Stock

  0.74LUCD Lucid DiagnosticsPairCorr
  0.73WM Waste ManagementPairCorr
  0.59GE GE AerospacePairCorr
  0.45PLX Protalix BiotherapeuticsPairCorr
  0.36PG Procter GamblePairCorr
  0.8JNJ Johnson JohnsonPairCorr
  0.76CVX Chevron CorpPairCorr
  0.74T ATT Inc Earnings Call TomorrowPairCorr
  0.67XOM Exxon Mobil CorpPairCorr
  0.66MMM 3M CompanyPairCorr
  0.52CSCO Cisco SystemsPairCorr
  0.52INTC IntelPairCorr
  0.51IBM International BusinessPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ABOSTERN
HOOKDAWN
INZYTERN
MREOTERN
PDSBTERN
HEPATERN
  
High negative correlations   
HOOKEFTR
HEPAEFTR
ELEVEFTR
EFTRMREO
EFTRABOS
EFTRINZY

Risk-Adjusted Indicators

There is a big difference between XFOR Stock performing well and X4 Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze X4 Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TERN  3.05 (0.92) 0.00 (1.16) 0.00 
 5.03 
 19.13 
DAWN  2.87 (0.52) 0.00 (0.64) 0.00 
 6.36 
 22.86 
PDSB  4.54 (0.22) 0.00 (0.38) 0.00 
 9.21 
 33.91 
INZY  4.07 (1.42) 0.00 (0.89) 0.00 
 6.82 
 36.29 
ABOS  2.99 (0.64) 0.00 (0.59) 0.00 
 6.57 
 19.77 
MREO  2.65 (0.57) 0.00 (0.84) 0.00 
 6.16 
 20.77 
EFTR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ELEV  5.06 (0.69) 0.00 (0.53) 0.00 
 8.33 
 68.94 
HEPA  9.87 (3.91) 0.00 (5.38) 0.00 
 16.37 
 90.05 
HOOK  3.63 (0.68) 0.00 (5.15) 0.00 
 7.00 
 32.80 

X4 Pharmaceuticals Corporate Management

Robert ArbeitSenior ResearchProfile
Mary DiBiaseChief OfficerProfile
Keith MDFounder BoardProfile
Pharm MPHVice CommunicationsProfile
Renato SkerljFounderProfile